![]() Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | ![]() Biological E Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines. | ||||
Founding Date | Founding Date 2007 | Founding Date 1953 | Founding Date 2003 | Founding Date 2004 | Founding Date N/A |
Type | Type Public | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Fremont, US HQ Waltham, US Waltham, US | Locations Hyderabad, IN HQ Hyderabad, IN Kolthur, IN Zug, CH Cary, US | Locations HQ | Locations Leederville, AU HQ | Locations Vadodara, IN HQ Ahmedabad, IN Mumbai, IN Vadodara, IN New York, US |
Employees | Employees 882% increase | Employees 4,3162% increase | Employees N/A | Employees 20 | Employees 832% decrease |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) 16.2 m | Valuation ($) 1 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $407.3m (FY, 2025) | Revenue (est.) ₹9.3b (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $1.5m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $39.5m (FY, 2025) | Cost of goods N/A | Cost of goods kr7.2m (FY, 2025) | Cost of goods $1.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $367.8m (FY, 2025) | Gross profit N/A | Gross profit (kr6.3m) (FY, 2025) | Gross profit ($143k) (FY, 2023) | Gross profit N/A |
Net income | Net income ($61.6m) (FY, 2025) | Net income N/A | Net income (kr56.1m) (FY, 2025) | Net income ($6.4m) (FY, 2023) | Net income N/A |

Biological E (also known as BE, formerly Biological Products Private) is a biological products and pharmaceuticals company that manufacturer and supplies vaccines.
View companySpectraCure is a company that provides treatment of internal solid cancer tumors.
View companyWELLFULLY is a company that provides product performance enhancement solutions.
View company